Amgen Inc.
AMGN
$312.47
-$2.25-0.72%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 21.76% | 19.55% | 4.99% | 6.40% | 2.01% |
| Total Other Revenue | 27.03% | 26.48% | -14.46% | -3.19% | -48.92% |
| Total Revenue | 21.98% | 19.84% | 3.77% | 5.94% | -2.13% |
| Cost of Revenue | 86.05% | 78.13% | 13.66% | 20.07% | 10.19% |
| Gross Profit | -3.15% | -0.16% | 0.67% | 1.75% | -6.24% |
| SG&A Expenses | 43.72% | 44.66% | 4.12% | -2.49% | 2.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -27.97% | 8,957.14% | -181.82% | -89.48% | -- |
| Total Operating Expenses | 54.44% | 62.38% | 5.43% | -3.58% | 11.50% |
| Operating Income | -48.44% | -69.68% | 1.28% | 25.28% | -22.65% |
| Income Before Tax | -101.98% | -51.26% | -18.60% | 5.42% | 105.49% |
| Income Tax Expenses | -92.51% | -35.61% | -12.85% | 9.81% | 202.01% |
| Earnings from Continuing Operations | -103.98% | -52.54% | -19.27% | 4.71% | 92.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -103.98% | -52.54% | -19.27% | 4.71% | 92.48% |
| EBIT | -48.44% | -69.68% | 1.28% | 25.28% | -22.65% |
| EBITDA | -15.36% | -34.23% | 2.64% | 20.57% | -15.16% |
| EPS Basic | -103.96% | -52.54% | -19.27% | 4.71% | 97.53% |
| Normalized Basic EPS | -76.75% | -95.21% | 10.80% | -39.77% | -4.62% |
| EPS Diluted | -103.99% | -52.42% | -19.10% | 4.90% | 97.01% |
| Normalized Diluted EPS | -76.57% | -95.22% | 10.80% | -39.78% | -4.81% |
| Average Basic Shares Outstanding | 0.37% | 0.00% | 0.00% | 0.00% | -2.55% |
| Average Diluted Shares Outstanding | -0.37% | 0.19% | 0.00% | 0.00% | -2.36% |
| Dividend Per Share | 5.63% | 9.79% | 9.79% | 9.79% | 9.79% |
| Payout Ratio | -27.71% | 1.31% | 0.36% | 0.05% | -0.45% |
